636. Immunogenicity, Safety and Tolerability of a Booster Dose of Clostridium difficile Vaccine and 4 Year Antibody Persistence

BACKGROUND: Clostroidides difficile (C difficile) is a common cause of antibiotic-associated diarrhea. To date, there is no vaccine to prevent C. difficile infection (CDI). This extension of a phase 2 study explores the immunogenicity, safety, and tolerability of a 4th dose, and antibody persistence...

Descripción completa

Detalles Bibliográficos
Autores principales: Remich, Shon A, Kitchin, Nicholas, Pride, Michael W, Anderson, Annaliesa S, Li, Ping, Webber, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778284/
http://dx.doi.org/10.1093/ofid/ofaa439.830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778284/
http://dx.doi.org/10.1093/ofid/ofaa439.830

Ejemplares similares